Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD

E-ISSN： 1873-5592|19|16|1882-1896

ISSN： 1389-4501

Source： Current Drug Targets, Vol.19, Iss.16, 2018-12, pp. : 1882-1896

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Biomarkers in Asthma and COPD

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 14, 2016-06 ,pp. : 1599-1609

Bentham Science Publishers

Access to resources Recommend Favorite

Neutrophils and Eosinophils: Clinical Implications of their Appearance, Presence and Disappearance in Asthma and COPD

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 4, 2005-08 ,pp. : 415-423

Bentham Science Publishers

Access to resources Recommend Favorite

Novel bronchodilators in the treatment of asthma and COPD

By Campillo Nuria Páez Juan Antonio

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 1, 2001-01 ,pp. : 53-63

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD

Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. : 3253-3262

Bentham Science Publishers

Access to resources Recommend Favorite

Open Questions on Guidelines for Treatment of Asthma and COPD

By Paggiaro P.L. Bacci E. Dente F.L. Di Franco A. Giannini D. Vagaggini B.

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 5, 1998-10 ,pp. : 401-405

Academic Press

Access to resources Recommend Favorite